Table 2.
Variable | Cut-off | Sensitivity (95% CI) | Specificity (95% CI) | AUC (95% CI) | PPV (95% CI) | NPV (95% CI) | Accuracy (95% CI) | P |
ELF score | 10.0 | 92.3 (0.669–0.987) | 66.7 (0.583–0.810) | 0.81 (0.67–0.92) | 45.9 (0.295–0.631) | 96 (0.863–0.995) | 74.7 (0.643–0.834) | |
TIMP-1 | 270 | 76.9 (0.462–0.950) | 72.2 (0.604–0.821) | 0.75 (0.59–0.92) | 33.3 (0.173–0.528) | 94.5 (0.849–0.989) | 72.9 (0.622–0.820) | .538 |
P-III-P | 13.5 | 76.9 (0.462–0.950) | 74.6 (0.629–0.842) | 0.80 (0.69–0.94) | 35.7 (0.186–0.559) | 94.6 (0.851–0.989) | 75.0 (0.644–0.838) | .94 |
HA | 125 | 53.3 (0.266–0.787) | 76.6 (0.656–0.855) | 0.67 (0.50–0.83) | 30.8 (0.143–0.518) | 89.4 (0.794–0.956) | 72.8 (0.626–0.816) | .059 |
Pro-C3 | 12.5 | 94.4 (0.727–0.999) | 38.1 (0.277–0.493) | 0.74 (0.62–0.86) | 24.6 (0.151–0.365) | 97.0 (0.842 – 0.999) | 48.0 (0.380–0.582) | .821 |
M2BPGi | 0.9 | 66.7 (0.349–0.901) | 61.4 (0.490–0.728) | 0.63 (0.45–0.81) | 22.9 (0.104–0.401) | 91.5 (0.796–0.976) | 62.2 (0.508–0.727) | .046 |
Fib-4 index | 2.16 | 69.2 (0.386–0.909) | 57.9 (0.460–691) | 0.64 (0.48–0.80) | 22.0 (0.106–0.376) | 91.7 (0.800–0.977) | 59.6 (0.486–0.698) | .156 |
APRI | 0.73 | 84.6 (0.546–0.981) | 59.2 (0.473–0.704) | 0.74 (0.62–0.85) | 26.2 (0.139–0.420) | 95.7 (0.855–0.995) | 62.9 (0.525–0.729) | .859 |
7S collagen | 4.1 | 73.3 (0.449–0.922) | 59.2 (0.473–0.704) | 0.65 (0.49–0.81) | 26.2 (0.139–0.420) | 91.8 (0.804–0.977) | 61.5 (0.508–0.716) | .647 |
Platelet | 22.9 | 71.4 (0.419–0.916) | 51.9 (0.403–0.635) | 0.67 (0.53–0.82) | 21.3 (0.107–0.357) | 90.9 (0.783–0.975) | 54.9 (0.442–0.654) | .129 |
4C7S = 7S domain of type 4 collagen, APRI = the aspartate aminotransferase-to-platelet ratio index, ELF score = Enhances Liver Fibrosis score, Fib-4 = the fibrosis index based on four factors, M2BPGi = Mac-2-binding protein glycosylation isomer, PBC = primarily biliary cholangitis, Pro-C3 = N-terminal type III collagen propeptide.